Compare TG Therapeutics Inc (TGTX) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs TeraWulf Inc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while TeraWulf Inc trades at $19.95 (market cap $9.35B). The key difference: TG Therapeutics Inc and TeraWulf Inc are close in size by market cap, and TG Therapeutics Inc is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals.
| TGTX | WULF | |
|---|---|---|
Market Cap | $8.26B | $9.35B |
Sector | Health | Technology |
52-Week High | $59.06 | $28.98 |
52-Week Low | $26.39 | $4.76 |
Enterprise Value | $8.50B | $12.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
